No Prescription |
 |
 | ||
|
Geftinet Iressa |
|
| ||
No Prescription » Prescription Drugs 8 » Geftinet Iressa This medication is used alone to treat lung cancer after other cancer chemotherapy treatments have not been successful. It is a cancer chemotherapy drug which works by blocking a certain protein (an enzyme called tyrosine kinase) which may help cancer grow and spread.How to use Gefitinib OralTake gefitinib by mouth once daily with or without food or as directed.Medications which reduce or completely block stomach acid (e.g. proton pump inhibitors/PPIs H2 blockers antacids) may decrease the absorption of gefitinib. This could decrease the effectiveness of gefitinib. Consult your doctor or pharmacist if you are taking any of these medications.Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time each day.Gefitinib Oral is used to treat the following:Non-Small Cell Lung Cancer Epithelial Growth Factor Receptor Positive Non-Small Cell Lung Cancer Buy Geftinet Iressa and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About Geftinet Iressa: Product Type: Prescription Drugs 8 Geftinet ( Iressa Generic Gefitinib ) Geftinet (Iressa Generic Gefitinib) Iressa Generic Gefitinib 250mg 3 x 30 Tablets 30 Tablets 2 x 30 Tablets Iressa Generic Gefitinib Geftinet
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
